GLP-1 has numerous physiological effects that are desirable in the management of type 2 diabetes and obesity, including regulation of insulin secretion, slowing gastric emptying, suppressing appetite and regulating carbohydrate metabolism. This evidence concerns the gene GLP1R and obesity due to melanocortin 4 receptor deficiency.